RNA Clinical Trials Resources

71. Head and Neck Cancer – Global Clinical Trial Landscape - Focus On Asia Pacific 9/11/2023

    Get a full overview of the current clinical trial landscape as it relates to HNC and where treatment efforts are headed in the future.

72. Staying On Top Of Changing FDA Regulations To Avoid Clinical Holds 8/14/2023

    As the biotech industry has grown exponentially, so has the number of FDA clinical holds. Biotech companies need strategic planning to avoid or quickly resolve costly clinical holds.

73. The Future Is Now: CGT Innovation, Challenges, And Perspectives 7/19/2023

    As CGTs advance toward clinical trials, developers face a number of challenges such as navigating a shifting regulatory landscape and employing beneficial manufacturing processes.

74. Advancing Cell And Gene Therapy Clinical Development In 2023 7/19/2023

    Examine considerations on bringing together the CMC and clinical teams early in the development process, promoting transparency and communication with regulators, and increasing patient access and diversity in clinical trials.

75. Moving CGTx Clinical Development Forward In 2023 6/27/2023

    Gain insights on cell and gene therapy (CGTx) clinical trial design and commercialization strategies as a panel of industry experts share their considerations.

76. Expectations On The Pathway To GMP For Gene-Modified Cell Therapies 6/21/2023

    Learn how a robust understanding of the RNP’s critical process parameters and CQAs is crucial for ensuring product consistency, enhancing patient safety, and maintaining regulatory compliance.

77. RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific 5/17/2023

    Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.

78. The Cell & Gene Therapy Clinical Trials Global Landscape 5/9/2023

    Gain valuable insights into the current state of cell and gene therapy clinical trials and the opportunities and challenges in this rapidly evolving field.

79. What Are The Benefits Of A Well-Designed, Robust Preclinical Development Plan? 5/9/2023

    Discover how a well-designed and robust preclinical development plan can help identify potential safety and efficacy issues early in the drug development process, ultimately reducing the risk of failure in clinical trials.

80. Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific 5/9/2023

    Unearth key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in popular trial regions of Asia Pacific, the United States, and Europe.